Lexaria Bioscience (LEXX) Earnings Analysis
Lexaria Bioscience (LEXX) next reports earnings on 2026-10-28, consensus EPS -0.06 USD. Last quarter (2026-07-13) it missed with EPS -0.08 USD vs -0.06 USD est (-33.3%). It has beaten estimates in 4/8 recent quarters (50%). Trailing P/E -1.58.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does LEXX next report earnings?
| Next earnings date | 2026-10-28 |
|---|---|
| Consensus EPS estimate | -0.06 USD |
| Revenue estimate | 0.00B |
LEXX earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-07-13 | -0.08 USD | -0.06 USD | -33.3% | Miss |
| 2026-04-13 | -0.06 USD | -0.1 USD | +40% | Beat |
| 2026-01-13 | -0.07 USD | -0.13 USD | +46.2% | Beat |
| 2025-11-26 | -0.13 USD | -0.16 USD | +18.8% | Beat |
| 2025-07-14 | -0.21 USD | -0.15 USD | -40% | Miss |
| 2025-04-14 | -0.15 USD | -0.16 USD | +6.3% | Beat |
| 2025-01-10 | -0.16 USD | -0.12 USD | -33.3% | Miss |
| 2024-11-26 | -0.15 USD | -0.11 USD | -36.4% | Miss |
Beat rate: 4/8 (50%) over reported quarters with consensus data.
LEXX valuation and analyst view
| Trailing P/E | -1.58 |
|---|---|
| Trailing EPS | -0.3117 USD |
| Price / book | 2.93 |
| Dividend yield | 0.00% |
| Market cap | 0.01B |
| Analyst consensus | Buy (2 buy / 0 hold / 0 sell) |
| Avg price target | 1.5 USD |
Related research pages
Frequently asked questions
When is Lexaria Bioscience (LEXX)'s next earnings date?
Lexaria Bioscience is next scheduled to report on 2026-10-28, with a consensus EPS estimate of -0.06 USD and revenue estimate of 0.00B.
Did LEXX beat earnings last quarter?
In its 2026-07-13 report, LEXX posted EPS of -0.08 USD versus a -0.06 USD estimate — a miss of 33.3%.
What is LEXX's earnings track record?
Over the last 8 reported quarters with consensus data, LEXX beat estimates 4 times (50%).
What is LEXX's current P/E ratio and EPS?
LEXX trades at a trailing P/E of -1.58 on trailing EPS of -0.31170078566716564 USD.
What do analysts rate LEXX?
Analyst consensus is "Buy" across 2 ratings (0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell). Average 12-month price target: 1.5 USD.